» Articles » PMID: 34388333

The Effect of SARS-CoV-2 on the Nervous System: a Review of Neurological Impacts Caused by Human Coronaviruses

Overview
Journal Rev Neurosci
Publisher De Gruyter
Specialty Neurology
Date 2021 Aug 13
PMID 34388333
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

The COVID-19 pandemic has affected millions of people worldwide. While coronaviruses typically have low rates of neurotropic effects, the massive transmission of SARS-CoV-2 suggests that a substantial population will suffer from potential SARS-CoV-2-related neurological disorders. The rapid and recent emergence of SARS-CoV-2 means little research exists on its potential neurological effects. Here we analyze the effects of similar viruses to provide insight into the potential effects of SARS-CoV-2 on the nervous system and beyond. Seven coronavirus strains (HCoV-OC43, HCoV-HKU1, HCoV-229E, HCoV-NL63, SARS-CoV, MERS-CoV, SARS-CoV-2) can infect humans. Many of these strains cause neurological effects, such as headaches, dizziness, strokes, seizures, and critical illness polyneuropathy/myopathy. Certain studies have also linked coronaviruses with multiple sclerosis and extensive central nervous system injuries. Reviewing these studies provides insight into the anticipated effects for patients with SARS-CoV-2. This review will first describe the effects of other coronaviruses that have caused severe disease (SARS-CoV, MERS-CoV) on the nervous system, as well as their proposed origins, non-neurological effects, and neurological infection mechanisms. It will then discuss what is known about SARS-CoV-2 in these areas with reference to the aforementioned viruses, with the goal of providing a holistic picture of SARS-CoV-2.

Citing Articles

The Potential Role of SARS-CoV-2 Infection and Vaccines in Multiple Sclerosis Onset and Reactivation: A Case Series and Literature Review.

Tavazzi E, Pichiecchio A, Colombo E, Rigoni E, Asteggiano C, Vegezzi E Viruses. 2023; 15(7).

PMID: 37515255 PMC: 10385211. DOI: 10.3390/v15071569.

References
1.
Teman N, Thomas J, Bryner B, Haas C, Haft J, Park P . Inhaled nitric oxide to improve oxygenation for safe critical care transport of adults with severe hypoxemia. Am J Crit Care. 2015; 24(2):110-7. DOI: 10.4037/ajcc2015570. View

2.
Anand P, Al-Faraj A, Sader E, Dashkoff J, Abdennadher M, Murugesan R . Seizure as the presenting symptom of COVID-19: A retrospective case series. Epilepsy Behav. 2020; 112:107335. PMC: 7373049. DOI: 10.1016/j.yebeh.2020.107335. View

3.
Arbour N, Day R, Newcombe J, Talbot P . Neuroinvasion by human respiratory coronaviruses. J Virol. 2000; 74(19):8913-21. PMC: 102086. DOI: 10.1128/jvi.74.19.8913-8921.2000. View

4.
Wang X, Fang J, Zhu Y, Chen L, Ding F, Zhou R . Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital. Clin Microbiol Infect. 2020; 26(8):1063-1068. PMC: 7195539. DOI: 10.1016/j.cmi.2020.03.032. View

5.
Sepehrinezhad A, Shahbazi A, Negah S . COVID-19 virus may have neuroinvasive potential and cause neurological complications: a perspective review. J Neurovirol. 2020; 26(3):324-329. PMC: 7229881. DOI: 10.1007/s13365-020-00851-2. View